CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome
about
An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors.Synergistic anti-tumor effect of bullfrog sialic acid-binding lectin and pemetrexed in malignant mesothelioma.Human canonical CD157/Bst1 is an alternatively spliced isoform masking a previously unidentified primate-specific exon included in a novel transcript.Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma.
P2860
CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
CD157 enhances malignant pleur ...... predicts poor clinical outcome
@ast
CD157 enhances malignant pleur ...... predicts poor clinical outcome
@en
CD157 enhances malignant pleur ...... predicts poor clinical outcome
@nl
type
label
CD157 enhances malignant pleur ...... predicts poor clinical outcome
@ast
CD157 enhances malignant pleur ...... predicts poor clinical outcome
@en
CD157 enhances malignant pleur ...... predicts poor clinical outcome
@nl
prefLabel
CD157 enhances malignant pleur ...... predicts poor clinical outcome
@ast
CD157 enhances malignant pleur ...... predicts poor clinical outcome
@en
CD157 enhances malignant pleur ...... predicts poor clinical outcome
@nl
P2093
P2860
P50
P356
P1433
P1476
CD157 enhances malignant pleur ...... predicts poor clinical outcome
@en
P2093
Ada Funaro
Alice Giacomino
Enrico Ruffini
Enza Ferrero
Erika Ortolan
Francesca Martinetto
Giorgio Scagliotti
Sara Orecchia
Silvia Novello
P2860
P304
P356
10.18632/ONCOTARGET.2186
P407
P577
2014-08-01T00:00:00Z